Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 HKD | +5.19% |
|
+9.09% | +7.69% |
04/07 | Ascentage Grants Takeda Exclusive Option for Licensing of Blood Cancer Drug | MT |
21/06 | Ascentage Pharma Group Completes $75 Million Share Subscription Deal with Takeda International | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.69% | 1.11B | |
+21.64% | 127B | |
+24.51% | 117B | |
+26.72% | 27.67B | |
-18.44% | 20.33B | |
-15.34% | 16.79B | |
-17.44% | 15.63B | |
+13.54% | 14.84B | |
-47.70% | 14.65B | |
+57.34% | 14.43B |
- Stock Market
- Equities
- 6855 Stock
- News Ascentage Pharma Group International
- Ascentage Grants Takeda Exclusive Option for Licensing of Blood Cancer Drug